EU probes Novo’s weight-loss drugs on reports of suicide risks

The European Medicines Agency is looking into Novo Nordisk’s weight-loss drugs Saxenda and Ozempic after “several reports of suicidal risks” were referred to the watchdog, Bloomberg News reported on Monday.

[#translated_full_content]  [#item_full_content]

Leave a Reply

Your email address will not be published. Required fields are marked *